GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 18, 2024 |
PDB ID ▼ | UniProt ID | Title | Descriptor |
---|---|---|---|
7LBG | Q8BCU3 | CryoEM structure of the HCMV Trimer gHgLgO in complex with human Transforming growth factor beta receptor type 3 and neutralizing fabs 13H11 and MSL-109 | |
7LBG | Q03167 | CryoEM structure of the HCMV Trimer gHgLgO in complex with human Transforming growth factor beta receptor type 3 and neutralizing fabs 13H11 and MSL-109 | |
7LBG | 7LBG | CryoEM structure of the HCMV Trimer gHgLgO in complex with human Transforming growth factor beta receptor type 3 and neutralizing fabs 13H11 and MSL-109 | |
7LBF | Q6SW67 | CryoEM structure of the HCMV Trimer gHgLgO in complex with human Platelet-derived growth factor receptor alpha and neutralizing fabs 13H11 and MSL-109 | |
7LBF | F5HCH8 | CryoEM structure of the HCMV Trimer gHgLgO in complex with human Platelet-derived growth factor receptor alpha and neutralizing fabs 13H11 and MSL-109 | |
7LBF | Q8BCU3 | CryoEM structure of the HCMV Trimer gHgLgO in complex with human Platelet-derived growth factor receptor alpha and neutralizing fabs 13H11 and MSL-109 | |
7LBF | P16234 | CryoEM structure of the HCMV Trimer gHgLgO in complex with human Platelet-derived growth factor receptor alpha and neutralizing fabs 13H11 and MSL-109 | |
7LBF | 7LBF | CryoEM structure of the HCMV Trimer gHgLgO in complex with human Platelet-derived growth factor receptor alpha and neutralizing fabs 13H11 and MSL-109 | |
7LBE | Q6SW67 | CryoEM structure of the HCMV Trimer gHgLgO in complex with neutralizing fabs 13H11 and MSL-109 | |
7LBE | F5HCH8 | CryoEM structure of the HCMV Trimer gHgLgO in complex with neutralizing fabs 13H11 and MSL-109 | |
7LBE | Q8BCU3 | CryoEM structure of the HCMV Trimer gHgLgO in complex with neutralizing fabs 13H11 and MSL-109 | |
7LBE | 7LBE | CryoEM structure of the HCMV Trimer gHgLgO in complex with neutralizing fabs 13H11 and MSL-109 | |
7LBC | P19440 | Structure of human GGT1 in complex with Lnt2-65 compound | |
7LAW | Q9UNG2 | crystal structure of GITR complex with GITR-L | |
7LAW | Q9Y5U5 | crystal structure of GITR complex with GITR-L | |
7LAQ | A0A3I4HTM2 | Crystal structure of Campylobacter jejuni Cj0843c lytic transglycosylase in complex with N,N'-diacetylchitobiose | |
7LAN | P05164 | CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-30 AKA 7-[(3~{S},4~{R},6~{R})-4-benzyl-2-oxa-7,13,14-triazatetracyclo[14.3.1.1^{3,6}.1^{11,14}]docosa-1(19),11(21),12,16(20),17-pentaen-10-yl]-3~{H}-triazolo[4,5-b]pyridin-5-amine | |
7LAM | A0A3I4HTM2 | Crystal structure of Campylobacter jejuni Cj0843c lytic transglycosylase in complex with N,N',N''-triacetylchitotriose | |
7LAL | P05164 | CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-18 AKA 7-(3-(2,3-DIHYDRO-1H-INDEN-1-YLAMINO)-1-PHENYLPROPYL)-1H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE | |
7LAG | P05164 | CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH Compound-14 AKA 7-({1-[(3-phenoxyphenyl)methyl]-1H-pyrazol-4-yl}methyl)-3H-[1,2,3]triazolo[4,5-b]pyridin-5-amine | |
7LAE | P05164 | CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH Compound-4 | |
7LAB | P0DTC2 | Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1052 | |
7LAB | 7LAB | Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1052 | |
7LAA | P0DTC2 | Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1041 | |
7LAA | 7LAA | Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1041 | |
7LA8 | 7LA8 | O6 variable lymphocyte receptor ectodomain bound to 3-HSO3-Gal-4GlcNAc | |
7LA5 | P19440 | Structure of human GGT1 in complex with Lnt1-172 compound. | |
7LA4 | P08514 | Integrin AlphaIIbBeta3-PT25-2 Complex | |
7LA4 | P05106 | Integrin AlphaIIbBeta3-PT25-2 Complex | |
7LA4 | 7LA4 | Integrin AlphaIIbBeta3-PT25-2 Complex | |
7L90 | 7L90 | BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-8 from animal Rh.33311 (Wk26 time point) | |
7L8Z | 7L8Z | BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-7 from animal Rh.33311 (Wk26 time point) | |
7L8Y | 7L8Y | BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-5 from animal Rh.33311 (Wk26 time point) | |
7L8X | 7L8X | BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-4 from animal Rh.33311 (Wk26 time point) | |
7L8W | 7L8W | BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-3 from animal Rh.33311 (Wk26 time point) | |
7L8U | 7L8U | BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-2 from animal Rh.33311 (Wk26 time point) | |
7L8T | 7L8T | BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-1 from animal Rh.33311 (Wk26 time point) | |
7L8S | 7L8S | BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-4 from animal Rh.33172 (Wk38 time point) | |
7L8P | P08514 | Integrin alphaIIbbeta3 in complex with sibrafiban | |
7L8P | P05106 | Integrin alphaIIbbeta3 in complex with sibrafiban | |
7L8P | 7L8P | Integrin alphaIIbbeta3 in complex with sibrafiban | |
7L8G | Q2N0S5 | BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-3 from animal Rh.33172 (Wk38 time point) | |
7L8G | 7L8G | BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-3 from animal Rh.33172 (Wk38 time point) | |
7L8F | Q2N0S5 | BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-2 from animal Rh.33172 (Wk38 time point) | |
7L8F | 7L8F | BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-2 from animal Rh.33172 (Wk38 time point) | |
7L8E | Q2N0S5 | BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-1 from animal Rh.33172 (Wk38 time point) | |
7L8E | 7L8E | BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-1 from animal Rh.33172 (Wk38 time point) | |
7L8D | 7L8D | BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-4 from animal Rh.33104 (Wk26 time point) | |
7L8C | 7L8C | BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-3 from animal Rh.33104 (Wk26 time point) | |
7L8B | 7L8B | BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-2 from animal Rh.33104 (Wk26 time point) |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024